Vaccination of myeloma patients with monoclonal immunoglobulin loaded dendritic cells:: preclinical and first clinical results of a phase I/II clinical trial

被引：0
|
作者：
Ocadlikova, D.
Zahradova, L.
Kovarova, L.
Smejkalova, J.
Pour, L.
Vidlakova, P.
Kyjovska, D.
Stejskalova, A.
Novotna, H.
Penka, M.
Michalek, J.
Hajek, R.
机构：
[1] Masaryk Univ, Cell Immunotherapy Ctr, Brno, Czech Republic
[2] Univ Hosp, Dept Hematooncol, Brno, Czech Republic
[3] Univ Hosp, Dept Pediat 1, Brno, Czech Republic
[4] Univ Hosp, Dept Clin Hematol, Brno, Czech Republic
[5] Univ Hosp, Dept Clin Biochem, Brno, Czech Republic
来源：
BLOOD REVIEWS | 2007年 / 21卷
关键词：
D O I：
10.1016/S0268-960X(07)70213-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [1] The preparation of monoclonal immunoglobulin loaded dendritic cells vaccine for myeloma patients under gmp conditions: Preclinical and first clinical results ofa phase I/II clinical trial
    Ocadlikova, D.
    Zahradova, L.
    Kovarova, L.
    Smejkalova, J.
    Pour, L.
    Vidlakova, P.
    Kyjovska, D.
    Stejskalova, A.
    Novotna, H.
    Penka, M.
    Michalek, J.
    Hajek, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 353 - 353
  • [2] Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells:: preclinical results and outcome of a first clinical phase I/II trial
    Märten, A
    Flieger, D
    Renoth, S
    Weineck, S
    Albers, P
    Compes, M
    Schöttker, B
    Ziske, C
    Engelhart, S
    Hanfland, P
    Krizek, L
    Faber, C
    von Ruecker, A
    Müller, S
    Sauerbruch, T
    Schmidt-Wolf, IGH
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2002, 51 (11-12) : 637 - 644
  • [3] Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial
    Angela Märten
    Dimitri Flieger
    Sabine Renoth
    Silvia Weineck
    Peter Albers
    Markus Compes
    Björn Schöttker
    Carsten Ziske
    Steffen Engelhart
    Peter Hanfland
    Ludmila Krizek
    Cora Faber
    Alexander von Ruecker
    Stefan Müller
    Tilman Sauerbruch
    Ingo G. Schmidt-Wolf
    Cancer Immunology, Immunotherapy, 2002, 51 : 637 - 644
  • [4] Phage idiotype vaccination: first phase I/II clinical trial in patients with multiple myeloma
    Roehnisch, Tim
    Then, Cornelia
    Nagel, Wolfgang
    Blumenthal, Christina
    Braciak, Todd
    Donzeau, Mariel
    Boehm, Thomas
    Flaig, Michael
    Bourquin, Carole
    Oduncu, Fuat S.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [5] Phage idiotype vaccination: first phase I/II clinical trial in patients with multiple myeloma
    Tim Roehnisch
    Cornelia Then
    Wolfgang Nagel
    Christina Blumenthal
    Todd Braciak
    Mariel Donzeau
    Thomas Böhm
    Michael Flaig
    Carole Bourquin
    Fuat S Oduncu
    Journal of Translational Medicine, 12
  • [6] Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: Results of a clinical phase I/II trial
    Yamanaka, R
    Homma, J
    Yajima, N
    Tsuchiya, N
    Sano, M
    Kobayashi, T
    Yoshida, S
    Abe, T
    Narita, M
    Takahashi, M
    Tanaka, R
    CLINICAL CANCER RESEARCH, 2005, 11 (11) : 4160 - 4167
  • [7] Clinical Evaluation of Dendritic Cell Vaccination for Patients with Recurrent Glioma: Results of a Clinical Phase I/II Trial
    Yamanaka, Ryuya
    Homma, Junpei
    Yajima, Naoki
    Sano, Masakazu
    Takahashi, Masuhiro
    MOLECULAR THERAPY, 2006, 13 : S106 - S106
  • [8] Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells
    Tetsuro Kikuchi
    Yasuharu Akasaki
    Masaki Irie
    Sadamu Homma
    Toshiaki Abe
    Tsuneya Ohno
    Cancer Immunology, Immunotherapy, 2001, 50 : 337 - 344
  • [9] Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells
    Kikuchi, T
    Akasaki, Y
    Irie, M
    Homma, S
    Abe, T
    Ohno, T
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2001, 50 (07) : 337 - 344
  • [10] AUTOLOGOUS DENDRITIC CELL VACCINATION IN MULTIPLE MYELOMA PATIENTS - A FIRST CLINICAL RESULTS AND SAFETY EVALUATION IN A PHASE 11 CLINICAL TRIAL
    Zahradova, L. Z.
    Ocadlikova, D.
    Kovarova, L.
    Smejkalova, J.
    Pour, L.
    Penka, M.
    Michalek, J.
    Hajek, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 241 - 241
12345